The war of words in the wrangle for control of NYSE Euronext has intensified ahead of a meeting of NYSE Euronext shareholders this week.
On Thursday, NYSE Euronext rejected the renewed offer from
Nasdaq and ICE for the company despite the 15% premium, based
on share prices on 20 April, the day before the rejection of
This was the second time that NYSE Euronext had rejected a
hostile bid from Nasdaq/ICE, the first coming on April 9.
At the time, board cited concerns over "execution risk"
relating to antitrust issues and questioned the whether a
break-up of the company outlined in the Nasdaq/ICE bid would
provide long-term value to shareholders.
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |